These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17383068)

  • 21. In silico 3-D structure prediction and molecular docking studies of inosine monophosphate dehydrogenase from Plasmodium falciparum.
    Raza M; Khan Z; Ahmad A; Raza S; Khan A; Mohammadzai IU; Zada S
    Comput Biol Chem; 2017 Dec; 71():10-19. PubMed ID: 28957725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
    Barnes BJ; Eakin AE; Izydore RA; Hall IH
    Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical analysis of the modular enzyme inosine 5'-monophosphate dehydrogenase.
    Nimmesgern E; Black J; Futer O; Fulghum JR; Chambers SP; Brummel CL; Raybuck SA; Sintchak MD
    Protein Expr Purif; 1999 Nov; 17(2):282-9. PubMed ID: 10545277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
    Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
    Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
    Buckley GM; Davies N; Dyke HJ; Gilbert PJ; Hannah DR; Haughan AF; Hunt CA; Pitt WR; Profit RH; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Feb; 15(3):751-4. PubMed ID: 15664851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
    Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
    J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolic acid analogs with a modified metabolic profile.
    Chen L; Wilson DJ; Labello NP; Jayaram HN; Pankiewicz KW
    Bioorg Med Chem; 2008 Oct; 16(20):9340-5. PubMed ID: 18809333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMP dehydrogenase: structural schizophrenia and an unusual base.
    Hedstrom L; Gan L
    Curr Opin Chem Biol; 2006 Oct; 10(5):520-5. PubMed ID: 16919497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tritrichomonas foetus: a strategy for structure-based inhibitor design of a protozoan inosine-5'-monophosphate dehydrogenase.
    Luecke H; Prosise GL; Whitby FG
    Exp Parasitol; 1997 Nov; 87(3):203-11. PubMed ID: 9371085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.
    Chen L; Wilson D; Jayaram HN; Pankiewicz KW
    J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
    Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolyl endopeptidase inhibitory activity of unsaturated fatty acids.
    Park YS; Jang HJ; Lee KH; Hahn TR; Paik YS
    J Agric Food Chem; 2006 Feb; 54(4):1238-42. PubMed ID: 16478242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A three-dimensional pharmacophore model for IMPDH inhibitors.
    Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
    Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
    Schalk-Hihi C; Zhang YZ; Markham GD
    Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of retinol and retinoic acids on lipoxygenase activity.
    Goldreich D; Grossman S; Sofer Y; Breitbart E; Sklan D
    Int J Vitam Nutr Res; 1997; 67(1):4-9. PubMed ID: 9119612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity.
    Pankiewicz KW; Zatorski A; Watanabe KA
    Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.
    Sunohara K; Mitsuhashi S; Shigetomi K; Ubukata M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5140-4. PubMed ID: 23937979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory action of C22-fatty acids on DNA polymerases and DNA topoisomerases.
    Yonezawa Y; Hada T; Uryu K; Iijima H; Yoshida H; Mizushina Y
    Int J Mol Med; 2006 Oct; 18(4):583-8. PubMed ID: 16964408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free fatty acid-induced alterations in the steroid-binding properties of rat androgen-binding protein.
    Felden F; Martin ME; Gueant JL; Benassayag C; Nunez EA
    Biochem Biophys Res Commun; 1993 Jan; 190(2):602-8. PubMed ID: 8427602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.